| Patents for C07D 498 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms (21,960) |
|---|
| 06/10/2004 | WO2004047755A2 Fused bicyclic nitrogen-containing heterocycles |
| 06/10/2004 | US20040110778 A 3,10-diaza-benzo[e]azulene, 3,8,10-triaza-benzo[e]azulene, or 1,3a,6-triaza-as-indacene derivatives, used to treat anxiety, depression, a sleep disorder, or Alzheimer's dementia. |
| 06/10/2004 | US20040110759 Inhibitors of IkB kinase (I Kappa B Kinase); treating various diseases including asthma, osteoarthritis, rheumatoid arthritis, Alzheimer's disease, cancer, infections, and cardiac infarct |
| 06/10/2004 | US20040110749 Crop and weed selectivity |
| 06/09/2004 | EP1425010A1 Substituted indoles and their use as integrin antagonists |
| 06/09/2004 | EP1098897B1 Compounds, compositions, and methods for stimulating neuronal growth and elongation |
| 06/09/2004 | CN1503799A Antidepressant azaheterocyclylmethyl derivatives of 7,8-dihydro-1,6,9-trioxa-3-aza cyclopenta [A] naphthalene |
| 06/09/2004 | CN1503798A Antidepressant azaheterocyclylmethyl derivatives of oxaheterocycle-fused- [1,4]-derivatives of oxaheterocycle-fused-[1,4]-benzodioxans |
| 06/09/2004 | CN1503784A 2-lminopyrrolidine derivatives |
| 06/09/2004 | CN1503781A Process for the preparatino of 1,3-substituted indenes and aryl-fused azapolycyclic compounds |
| 06/09/2004 | CN1503671A Agent for topical ophthalmic treatment of ocular inflammatory diseases |
| 06/09/2004 | CN1152881C New indolocarbazole alkaloids from marine actinomycete, its composition and use |
| 06/09/2004 | CN1152877C Piperazine derivatives |
| 06/09/2004 | CN1152874C Antipsychotic 4 (1 H-indolyl-1-YL)-1-substituted piperidine derivatives |
| 06/08/2004 | US6747151 Azo compounds for type I phototherapy |
| 06/03/2004 | WO2004046152A1 Diazinopyrimidines |
| 06/03/2004 | WO2004046103A2 Arylpyridine compounds |
| 06/03/2004 | WO2004045668A1 Medical devices incorporating deuterated rapamycin for controlled delivery thereof |
| 06/03/2004 | WO2004045546A2 Water-soluble mesoporphyrin compounds and methods of preparation |
| 06/03/2004 | WO2004014868A3 Pyrimidine-2,4-dione derivatives as matrix metalloproteinase inhibitors |
| 06/03/2004 | US20040106662 Use of the disorazoles and their derivatives for the treatment of benign and malignant oncoses |
| 06/03/2004 | US20040106661 Broadspecturm 2-amino-benzoxazole sulfonamide hiv protease inhibitors |
| 06/03/2004 | US20040106655 pyrrolo-2yl-carbonyl-amino compounds; dipeptidyl peptidase inhibitor |
| 06/03/2004 | US20040106654 Inhibitors of copper-containing amine oxidases |
| 06/03/2004 | US20040106637 detecting the presence or absence of increased S6 kinase activity in said biological sample. |
| 06/03/2004 | US20040106604 Novel pyrrole derivatives as pharmaceutical agents |
| 06/03/2004 | US20040106599 an aromatic or heteroaromatic amide compound useful as antiproliferative agent |
| 06/03/2004 | US20040106590 Methods and reagents for treating infections of clostridium difficile and diseases associated therewith |
| 06/03/2004 | US20040106559 for inhibiting proteases |
| 06/03/2004 | CA2506565A1 Diazinopyrimidines |
| 06/03/2004 | CA2505080A1 Medical devices incorporating deuterated rapamycin for controlled delivery thereof |
| 06/02/2004 | EP1423394A2 A derivatized macrocycle compound for covalent bonding to a substrate and method of forming and use |
| 06/02/2004 | EP1423393A1 Cyclic indole and heteroindole derivatives, the production and use thereof as medicaments |
| 06/02/2004 | EP1423390A2 Purine inhibitors of phosphodiesterase (pde) 7 |
| 06/02/2004 | EP1423119A1 Heterobicycles fkbp-ligands |
| 06/02/2004 | EP1423110A2 Cbi analogues of cc-1065 and the duocarmycins |
| 06/02/2004 | EP1423006A1 Agonists and antagonists of 5h 3?-like receptors of invertebrate s as pesticides |
| 06/02/2004 | EP1259510B1 Tricyclic dihydropyrazolone and tricyclic dihydroisoxazolone potassium channel openers |
| 06/02/2004 | EP1182202B1 Aminomethylpyrrolidine derivatives having aromatic substituents |
| 06/02/2004 | CN1151787C Lactacystine analogs |
| 06/01/2004 | USRE38524 Dipeptide derivatives as growth hormone secretagogues |
| 06/01/2004 | US6743852 Benzoxazines, thermosetting resins comprised thereof, and methods for use thereof |
| 06/01/2004 | US6743815 Estrogen receptor modulators |
| 06/01/2004 | US6743794 Methods and compounds for inhibiting MRP1 |
| 06/01/2004 | US6743793 Dp receptor antagonist; prostaglandin d |
| 05/27/2004 | WO2004043367A2 Fused heterocyclic compounds and use thereof |
| 05/27/2004 | US20040102498 Estrogen receptor modulators |
| 05/26/2004 | EP1421939A1 Sustained release preparation of a macrolide compound like tacrolimus |
| 05/26/2004 | EP1421634A2 Organic electroluminescent device based on 2,5-diaminoterephthalic acid derivatives |
| 05/26/2004 | EP1421087A1 Diazacycloalkanes as oxytocin agonists |
| 05/26/2004 | EP1421074A1 Novel compounds |
| 05/26/2004 | EP1420787A2 Ophthalmic composition comprising an ascomycin |
| 05/26/2004 | EP1206474B1 Sulfonylphenylpyrazole compounds useful as cox-2 inhibitors |
| 05/26/2004 | CN1151152C New polycyclicazindole compound, its preparation method are medicine composition containing same |
| 05/26/2004 | CN1151151C Method for producing f-methoxy-quinoline carboxylic acids |
| 05/25/2004 | US6740656 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto |
| 05/25/2004 | US6740651 Aminoquinazolines which inhibit signal transduction mediated by tyrosine kinases |
| 05/21/2004 | WO2004041961A1 Photochromic compositions and light transmissible articles |
| 05/21/2004 | WO2004041209A2 Transcription factor modulating compounds and methods of use thereof |
| 05/21/2004 | WO2004041161A2 Tetrahydropyranyl cyclopentyl benzylamide modulators of chemokine receptor activity |
| 05/21/2004 | WO2004041158A2 Rifalazil compositions and therapeutic regimens |
| 05/21/2004 | WO2004014222A3 Diagnosis and treatment of tuberous sclerosis |
| 05/21/2004 | WO2003015780A8 Isoxazolopyridinones and use thereof in the treatment of parkinson's disease |
| 05/21/2004 | CA2502174A1 Tetrahydropyranyl cyclopentyl benzylamide modulators of chemokine receptor activity |
| 05/20/2004 | US20040097728 Method for producing anellated tetrahydro-{1h}-triazoles |
| 05/20/2004 | US20040097563 4-6-Diphenyl pyridine derivatives as antiinflammatory agents |
| 05/20/2004 | US20040097513 Novel non-imidazole compounds |
| 05/20/2004 | US20040097507 Useful for inhibiting resistant neoplasms where the resistance is conferred in part or in total by multidrug resistance protein MRP1 |
| 05/20/2004 | US20040097501 Triazole compounds useful as protein kinase inhibitors |
| 05/20/2004 | US20040097493 Diazinopyrimidines |
| 05/20/2004 | US20040097481 For therapy of hyperbilirubinemia |
| 05/19/2004 | EP1419167A1 1-(2,5'-anhydro-lyxofuranosyl) thymines for the synthesis of radiomarked fluoro-3 deoxynucleotides |
| 05/19/2004 | EP1418912A2 Isoxazolopyridinones |
| 05/19/2004 | EP1009738B1 Substituted oxindole derivatives as protein tyrosine kinase and as protein serine/threonine kinase inhibitors |
| 05/19/2004 | EP0947513B1 Tricyclic amine derivatives |
| 05/19/2004 | EP0874629B1 ISOXAZOLINE, ISOTHIAZOLINE AND PYRAZOLINE FACTOR Xa INHIBITORS |
| 05/19/2004 | EP0717736B1 Phosphorus derivatives to treat aids |
| 05/19/2004 | CN1498212A New spirotricyclic derivatives and their use as phosphodiesterase-7-inhibitors |
| 05/19/2004 | CN1150192C Piperidines as CCR5 modulators |
| 05/19/2004 | CN1150166C CB2 receptor agonist compounds |
| 05/19/2004 | CN1149996C Hexahydro-pyrido(4,3-B) indole derivatives as antipsychotic drugs |
| 05/13/2004 | WO2004039809A1 Novel quinoxaline derivatives |
| 05/13/2004 | WO2004024065A3 Substituted bicyclic thiophene derivatives, compostions containing such compounds and methods of use |
| 05/13/2004 | WO2003090684B1 Polymer compositions containing a macrocyclic triene compound |
| 05/13/2004 | US20040092538 Cycloalkyl alkanoic acids as integrin receptor antagonists derivatives |
| 05/13/2004 | US20040092502 Central nervous system disorders; dietetics; psychological disorders; sleep disorders; sexual disorders |
| 05/13/2004 | US20040092497 Heteroarylakanoic acids as intergrin receptor antagonists |
| 05/13/2004 | US20040092015 Coupling; binding aldehyde compound forming hydrazone compound; lipophilic vector |
| 05/12/2004 | EP1417162A1 Chromatographic separation of enantiomers of protected amino acids via smb-method |
| 05/12/2004 | EP1018514B1 NF-$g(k)B INHIBITORS CONTAINING INDAN DERIVATIVES AS THE ACTIVE INGREDIENT |
| 05/12/2004 | EP0960105B1 Benzofurazan compounds that enhance ampa receptor activity |
| 05/12/2004 | CN1149216C Tricylic benzoylcylohexanedione derivatives |
| 05/11/2004 | US6734203 Fused imidazolium derivatives |
| 05/11/2004 | US6734180 NF-κB inhibitor comprising an indan derivative as an active ingredient |
| 05/06/2004 | WO2004037831A1 Novel substituted[1,4]benzodioxino[2,3-e]isoindole derivatives, method for preparing same and pharmaceutical compositions containing same |
| 05/06/2004 | WO2004037829A1 Novel benzoxazole or oxazolopyridine compounds, method for preparing same and pharmaceutical compositions containing same |
| 05/06/2004 | WO2004037828A1 Process for producing optically active sulfoxide |
| 05/06/2004 | WO2004037800A1 Aryloxyalkylamine derivates as h3 receptor ligands |
| 05/06/2004 | WO2004016614A3 Pyrrolopyrazines as kinase inhibitors |
| 05/06/2004 | WO2003040096A3 N, n'-substituted-1,3-diamino-2-hydroxypropane derivatives |